Perron P

References (3)

Title : Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes - Perron_2007_J.Endocrinol.Invest_30_551
Author(s) : Perron P , Brisson D , Santure M , Blackburn P , Bergeron J , Vohl MC , Despres JP , Gaudet D
Ref : J Endocrinol Invest , 30 :551 , 2007
Abstract : Perron_2007_J.Endocrinol.Invest_30_551
ESTHER : Perron_2007_J.Endocrinol.Invest_30_551
PubMedSearch : Perron_2007_J.Endocrinol.Invest_30_551
PubMedID: 17848837

Title : Effect of obesity on HDL and LDL particle sizes in carriers of the null P207L or defective D9N mutation in the lipoprotein lipase gene: the Quebec LipD Study - Ruel_2003_Int.J.Obes.Relat.Metab.Disord_27_631
Author(s) : Ruel IL , Gaudet D , Perron P , Bergeron J , Julien P , Lamarche B
Ref : Int J Obes Relat Metab Disord , 27 :631 , 2003
Abstract : Ruel_2003_Int.J.Obes.Relat.Metab.Disord_27_631
ESTHER : Ruel_2003_Int.J.Obes.Relat.Metab.Disord_27_631
PubMedSearch : Ruel_2003_Int.J.Obes.Relat.Metab.Disord_27_631
PubMedID: 12704407

Title : Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients - Brisson_2002_Pharmacogenet_12_313
Author(s) : Brisson D , Ledoux K , Bosse Y , St-Pierre J , Julien P , Perron P , Hudson TJ , Vohl MC , Gaudet D
Ref : Pharmacogenetics , 12 :313 , 2002
Abstract : Brisson_2002_Pharmacogenet_12_313
ESTHER : Brisson_2002_Pharmacogenet_12_313
PubMedSearch : Brisson_2002_Pharmacogenet_12_313
PubMedID: 12042669